van den Elsen, S. H., Sturkenboom, M. G., Akkerman, O., Barkane, L., Bruchfeld, J., Eather, G., Heysell, S. K., Hurevich, H., Kuksa, L., Kunst, H., Kuhlin, J., Manika, K., Moschos, C., Mpagama, S. G., Muñoz Torrico, M., Skrahina, A., Sotgiu, G., Tadolini, M., Tiberi, S., Volpato, F., van der Werf, T. S., Wilson, M. R., Zúñiga, J., Touw, D. J., Migliori, G. B., & Alffenaar, J. (2020). prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study. BMJ open, 10(6), . http://access.bl.uk/ark:/81055/vdc_100130160619.0x00000a